Overview

Clopidogrel as Adjunctive Reperfusion Therapy - Thrombolysis in Myocardial Infarction

Status:
Completed
Trial end date:
2005-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if the combination of aspirin plus clopidogrel is more effective than aspirin alone in preventing another heart attack, chest pain, stroke or death in people who have already had a heart attack that was treated with fibrinolytic therapy.
Phase:
Phase 3
Details
Lead Sponsor:
Sanofi
Collaborator:
Bristol-Myers Squibb
Treatments:
Aspirin
Clopidogrel
Ticlopidine